Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

New variant, Omicron XE, detected in UK

April 6, 2022 Research and Development

A new sub-variant of Omicron has been found in the UK, as the country experiences a new surge of COVID-19.The …
News

Race to deliver HIV drugs to Ukraine

April 6, 2022 Research and Development

WHO is to supply thousands of antiretroviral drugs to Ukraine for patients living with HIV over the next year. UNAIDS, …
News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News

Iktos announces a collaboration with Ono for new drug design

March 30, 2022 Research and Development

Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …
News

$24 million in grants to help end HIV epidemic across the globe

March 30, 2022 Research and Development

Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …
News

Study finds COVID-19 may double severe complications in pregnancy

March 23, 2022 Research and Development

A Kaiser Permanente analysis of pregnant patients who tested positive for COVID-19 found more than double the risk of severe …
News

Alnylam sues Moderna and Pfizer over key vaccine ingredient

March 23, 2022 Research and Development

Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company, has sued Moderna and Pfizer over allegations that the firms used patented nanoparticle technology …
News

ONS says no evidence that COVID-19 vaccines lead to young deaths

March 23, 2022 Research and Development

The Office for National Statistics (ONS) has said that there is no evidence that COVID-19 vaccines have led to an …
News

Pfizer to supply UNICEF oral COVID-19 treatment for low- and middle-income countries

March 23, 2022 Research and Development

Pfizer have announced the signing of a supply agreement with the United Nations Children’s Fund (UNICEF), to deliver up to …
News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
Appointment

Sanofi and Seagen collaborate to develop novel antibody-drug conjugates

March 16, 2022 Research and Development

Sanofi and Seagen announced an exclusive collaboration agreement to design, develop, and commercialise antibody-drug conjugates (ADCs) for up to three …
News
national-cancer-institute-uurfmwa25f0-unsplash

NICE guidance for treating relapsed and refractory multiple myeloma

March 16, 2022 Research and Development

NICE has published guidance from the new cancer drug, daratumumab, for the treatment of relapsed and refractory myeloma. Around 350 …
News

FDA approves Symbicort to treat asthma and COPD

March 16, 2022 Research and Development

The FDA has approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, for the treatment of …
News

FDA clearance for clinical surveillance solution

March 16, 2022 Research and Development

The latest Philips Capsule Surveillance solution has received market clearance from the FDA, paving the way for widespread deployment across …
News

Vicore adds to rare lung disease pipeline with PAH indication

March 9, 2022 Research and Development

Vicore Pharma has announced plans to initiate a clinical trial with C21 in pulmonary arterial hypertension (PAH).
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026